Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
aztreonam lysine
|
| gptkbp:approvalYear |
2010
|
| gptkbp:ATCCode |
J01DF01
|
| gptkbp:brand |
gptkb:Cayston
|
| gptkbp:chemicalClass |
monobactam antibiotic
|
| gptkbp:form |
inhalation solution
|
| gptkbp:genericName |
aztreonam lysine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cayston
|
| gptkbp:indication |
cystic fibrosis
Pseudomonas aeruginosa lung infections |
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Gilead_Sciences
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:pregnancyCategory |
B
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
cough
nasal congestion wheezing pharyngolaryngeal pain |
| gptkbp:bfsParent |
gptkb:aztreonam
gptkb:Aztreonam_lysine_for_inhalation |
| gptkbp:bfsLayer |
7
|